Skip to content

Alkermes ALKS Deferred Tax Assets

Deferred Tax Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$5.18B+29.5%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
LQD
Liquidia CorporationLQDA
ALN
Alnylam PharmaceuticalsALNY
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's deferred tax assets?
Alkermes (ALKS) reported deferred tax assets of $134.81M in Q1 2026.
How has Alkermes's deferred tax assets changed year-over-year?
Alkermes's deferred tax assets decreased by 11.4% year-over-year, from $152.14M to $134.81M.
What is the long-term trend for Alkermes's deferred tax assets?
Over 5 years (2020 to 2025), Alkermes's deferred tax assets has grown at a 7.8% compound annual growth rate (CAGR), from $86.23M to $125.82M.
What does deferred tax assets mean?
Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.